In experimental migraine models, the brain activates genes coding for proteins protecting against oxidative and inflammatory events during the CSD (e.g., major prion protein, glutathione-S-transferase-5, and apolipoprotein E), hinting that under normal conditions the brain tries to counteract potentially harmful consequences of a benign headache disorder [37]. The gene discussed is PRNP; the disease is migraine disorder.